BE900564A - Composition pharmaceutique pour le traitement d'arteriopathies peripheriques. - Google Patents

Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.

Info

Publication number
BE900564A
BE900564A BE0/213641A BE213641A BE900564A BE 900564 A BE900564 A BE 900564A BE 0/213641 A BE0/213641 A BE 0/213641A BE 213641 A BE213641 A BE 213641A BE 900564 A BE900564 A BE 900564A
Authority
BE
Belgium
Prior art keywords
treatment
pharmaceutical composition
peripheral arteriopathies
peripheral
arteriopathies
Prior art date
Application number
BE0/213641A
Other languages
English (en)
French (fr)
Inventor
O N Ulutin
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Publication of BE900564A publication Critical patent/BE900564A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
BE0/213641A 1983-09-12 1984-09-12 Composition pharmaceutique pour le traitement d'arteriopathies peripheriques. BE900564A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22855/83A IT1170214B (it) 1983-09-12 1983-09-12 Composizione farmaceutica per la cura delle arteriopatie periferiche

Publications (1)

Publication Number Publication Date
BE900564A true BE900564A (fr) 1985-01-02

Family

ID=11201215

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213641A BE900564A (fr) 1983-09-12 1984-09-12 Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.

Country Status (8)

Country Link
US (1) US5081109A (enExample)
EP (1) EP0137543B1 (enExample)
JP (1) JPH0647545B2 (enExample)
AT (1) ATE55695T1 (enExample)
BE (1) BE900564A (enExample)
CH (1) CH661870A5 (enExample)
DE (1) DE3433328A1 (enExample)
IT (1) IT1170214B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US6699985B2 (en) * 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
DE19610345C1 (de) 1996-03-18 1997-11-20 Krupp Vdm Gmbh Katalysator zur Oxidation von Abwasserverunreinigungen mittels Persäuren und/oder Wasserstoffperoxid
HK1044896A1 (zh) * 1997-04-28 2002-11-08 Burcoglu Arsinur 治疗hiv感染和与之有关的继发感染的方法
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
MX2007010754A (es) * 2005-03-03 2007-11-07 Gentium Spa Defibrotide y/u oligodeoxiribonucleotidos para tratar tumores dependientes de angiogenesis.
EP1891952B1 (en) * 2006-05-04 2011-10-05 LEK Pharmaceuticals d.d. Pharmaceutical composition of olmesartan medoxomil
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
DK2637672T3 (en) 2010-11-12 2018-10-22 Gentium S R L DEFIBROTID FOR USE IN PROPHYLAXY AND / OR TREATMENT OF GRAPHIC VERSUS HOST DISEASE (GVHD)
KR20150044877A (ko) 2012-06-22 2015-04-27 젠티엄 에스피에이 디파이브로타이드의 생물학적 활성 측정을 위한 유우글로불린에 기초한 방법
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
KR20200121780A (ko) 2017-08-03 2020-10-26 재즈 파마슈티칼즈 아일랜드 리미티드 높은 농도에서 핵산을 포함하는 제제
BR112020020865A2 (pt) 2018-04-12 2021-01-19 Jazz Pharmaceuticals, Inc. Defibrotida para prevenção e tratamento da síndrome de liberação de citocinas e neurotoxicidade associadas à imunodepleção
US20220023533A1 (en) 2018-12-07 2022-01-27 Jazz Phrmaceticals Ireland Limited Subcutaneous delivery of high concentration formulations
EP4110287A1 (en) 2020-02-28 2023-01-04 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
US20230086833A1 (en) 2020-04-17 2023-03-23 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
TW202308659A (zh) 2021-05-06 2023-03-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
US4485105A (en) * 1978-10-12 1984-11-27 American Cyanamid Company Method of treating hyperlipidemia with 4-(monoalkylamino)benzoic acid amides
US4416877A (en) * 1979-02-13 1983-11-22 Symphar S.A. Anti-atherosclerotic pharmaceutical compositions containing diphosphonate compounds
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
JPS5675474A (en) * 1979-11-22 1981-06-22 Chugai Pharmaceut Co Ltd Nicotinamide derivative and medicine containing the same
US4351950A (en) * 1980-01-02 1982-09-28 Warner-Lambert Company Anti-arteriosclerotic agents
US4450272A (en) * 1982-05-06 1984-05-22 American Cyanamid Company Antiatherosclerotic 1-piperazine-thicarboxamides
IT1167197B (it) * 1983-07-25 1987-05-13 Bellon Roger Schoum Rbs Pharma Impiego della fenpiramina quale farmaco antiaggregante piastrinico,vasodilatatore,antitrombotico e antianginoso
IT1170215B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.

Also Published As

Publication number Publication date
JPH0647545B2 (ja) 1994-06-22
ATE55695T1 (de) 1990-09-15
DE3433328C2 (enExample) 1993-08-05
JPS6169722A (ja) 1986-04-10
EP0137543B1 (en) 1990-08-22
EP0137543A3 (en) 1987-09-02
CH661870A5 (it) 1987-08-31
US5081109A (en) 1992-01-14
IT1170214B (it) 1987-06-03
IT8322855A0 (it) 1983-09-12
DE3433328A1 (de) 1985-03-28
EP0137543A2 (en) 1985-04-17

Similar Documents

Publication Publication Date Title
BE900564A (fr) Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.
BE901737A (fr) Composition pharmaceutique pour le traitement de l'ischemie myocardique aigue.
CA2191129A1 (fr) Medicaments a base de metronidazole ou d'un melange synergetique de metronidazole et de clindamycine
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
BE853086A (fr) Compositions pharmaceutiques contenant comme ingredients actifs des derives de triazolo-pyrimidines utiles pour le traitement de psoriasis
BE901667A (fr) Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation.
EP0963200A4 (en) METHOD AND MEANS FOR INHIBITING ANGIOGENESIS
PT902789E (pt) Derivados de androsteno
DZ2186A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'ostéoporose et procédé pour leur préparation.
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
ES479474A1 (es) Procedimiento para la obtencion de una composicion a base dederivados de la piridina de accion cerebral.
KR970704429A (ko) 심혈관 질환의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of cardiovascular diseases)
OA09023A (fr) Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.
RU93004793A (ru) Производные хиназолина, способ их получения, фармацевтическая композиция на их основе
OA06533A (fr) Dérivés de la pyrimidine, procédés pour leur préparation, compositions pharmaceutiques contenant ces composés et leur utilisation thérapeutique.
BE854414A (fr) Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate
BE900563A (fr) Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue.
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
KR890001564A (ko) 약학적 투여 단위
BE891639A (fr) Compositions pharmaceutiques contenant de la gamma-butyro-betaine pour le traitement de syndromes provoques par une deficience en l-carnitine
KR950016760A (ko) 치질 치료제
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
FR2794976B1 (fr) Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CRINOS INDUSTRIA FARMACOBIOLOGICA S.P.A.

Effective date: 19970930